_id

6910545cccc777a4e85d5574

Ticker

CRDL

Name

Cardiol Therapeutics Inc Class A

Exchange

NASDAQ

Address

2265 Upper Middle Road East, Oakville, ON, Canada, L6H 0G5

Country

USA

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Currency

USD

Website

https://www.cardiolrx.com

Description

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.

Last Close

1.09

Volume

490382

Current Price

1.08

Change

-0.9174311926605512

Last Updated

2025-11-29T11:50:01.461Z

Image

data:image/webp;base64,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

Ipo Date

2019-01-15T00:00:00.000Z

Market Cap

104997528

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Rating

4.2

Target Price

7.8682

Strong Buy

1

Buy

4

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

10180100

Operating Income

-10180100

Interest Expense

-

Pretax Income

-9964281

Net Income

-9964281

Eps

-0.1176039968463095

Dividends Per Share

-

Shares Outstanding

99997648

Income Tax Expense

-

EBITDA

-9938730

Operating Margin

-

Total Other Income Expense Net

215819

Cash

11622408

Short Term Investments

-

Receivables

195880

Inventories

-

Total Current Assets

12806820

Property Plant Equipment

140981

Total Assets

12947801

Payables

-

Short Term Debt

36925

Long Term Debt

-

Total Liabilities

3386926

Equity

9560875

Depreciation

25551

Change In Working Capital

-622146

Cash From Operations

-6925011

Capital Expenditures

3018

Cash From Investing

-3018

Cash From Financing

-13844

Net Change In Cash

-6572644

PE

-

PB

9.570838765280376

ROE

-104.21934184894167

ROA

-76.95732271449029

FCF

-6928029

Fcf Percent

-

Piotroski FScore

1

Health Score

35

Deep Value Investing Score

3.5

Defensive Investing Score

5

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

3.5

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

4.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

10180100

Quarters > 0 > income Statement > operating Income

-10180100

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-9964281

Quarters > 0 > income Statement > net Income

-9964281

Quarters > 0 > income Statement > eps

-0.1176039968463095

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

84727401

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-9938730

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

215819

Quarters > 0 > balance Sheet > cash

11622408

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

195880

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

12806820

Quarters > 0 > balance Sheet > property Plant Equipment

140981

Quarters > 0 > balance Sheet > total Assets

12947801

Quarters > 0 > balance Sheet > payables

-

Quarters > 0 > balance Sheet > short Term Debt

36925

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

3386926

Quarters > 0 > balance Sheet > equity

9560875

Quarters > 0 > cash Flow > net Income

-9964281

Quarters > 0 > cash Flow > depreciation

25551

Quarters > 0 > cash Flow > change In Working Capital

-622146

Quarters > 0 > cash Flow > cash From Operations

-6925011

Quarters > 0 > cash Flow > capital Expenditures

3018

Quarters > 0 > cash Flow > cash From Investing

-3018

Quarters > 0 > cash Flow > cash From Financing

-13844

Quarters > 0 > cash Flow > net Change In Cash

-6572644

Quarters > 0 > ratios > PE

-0.1176039968463095

Quarters > 0 > ratios > PB

9.570838765280376

Quarters > 0 > ratios > ROE

-104.21934184894167

Quarters > 0 > ratios > ROA

-76.95732271449029

Quarters > 0 > ratios > FCF

-6928029

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

35

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

7676158

Quarters > 1 > income Statement > operating Income

-7676158

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-8354371

Quarters > 1 > income Statement > net Income

-8354371

Quarters > 1 > income Statement > eps

-0.1010771937885705

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

82653373

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-7650688

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

-678213

Quarters > 1 > balance Sheet > cash

18195052

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

279887

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

19774185

Quarters > 1 > balance Sheet > property Plant Equipment

163514

Quarters > 1 > balance Sheet > total Assets

19937699

Quarters > 1 > balance Sheet > payables

7987270

Quarters > 1 > balance Sheet > short Term Debt

35556

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

8129824

Quarters > 1 > balance Sheet > equity

11807875

Quarters > 1 > cash Flow > net Income

-8354371

Quarters > 1 > cash Flow > depreciation

25470

Quarters > 1 > cash Flow > change In Working Capital

671355

Quarters > 1 > cash Flow > cash From Operations

-4550574

Quarters > 1 > cash Flow > capital Expenditures

6439

Quarters > 1 > cash Flow > cash From Investing

-6439

Quarters > 1 > cash Flow > cash From Financing

20416

Quarters > 1 > cash Flow > net Change In Cash

-5097649

Quarters > 1 > ratios > PE

-0.1010771937885705

Quarters > 1 > ratios > PB

7.559839754401194

Quarters > 1 > ratios > ROE

-70.75253591353228

Quarters > 1 > ratios > ROA

-41.90238301822091

Quarters > 1 > ratios > FCF

-4557013

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

31

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

8429063

Quarters > 2 > income Statement > operating Income

-8429063

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-8287653

Quarters > 2 > income Statement > net Income

-8287653

Quarters > 2 > income Statement > eps

-0.1003238606276663

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

82608992

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-8404077

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

141410

Quarters > 2 > balance Sheet > cash

23292701

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

346690

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

25272350

Quarters > 2 > balance Sheet > property Plant Equipment

182545

Quarters > 2 > balance Sheet > total Assets

25454895

Quarters > 2 > balance Sheet > payables

7716431

Quarters > 2 > balance Sheet > short Term Debt

34252

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

7867091

Quarters > 2 > balance Sheet > equity

17587804

Quarters > 2 > cash Flow > net Income

-8287653

Quarters > 2 > cash Flow > depreciation

24986

Quarters > 2 > cash Flow > change In Working Capital

-151824

Quarters > 2 > cash Flow > cash From Operations

-7153767

Quarters > 2 > cash Flow > capital Expenditures

11939

Quarters > 2 > cash Flow > cash From Investing

-11939

Quarters > 2 > cash Flow > cash From Financing

-13844

Quarters > 2 > cash Flow > net Change In Cash

-7287328

Quarters > 2 > ratios > PE

-0.1003238606276663

Quarters > 2 > ratios > PB

5.0727032982628195

Quarters > 2 > ratios > ROE

-47.12159062040946

Quarters > 2 > ratios > ROA

-32.558189692002266

Quarters > 2 > ratios > FCF

-7165706

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

38

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

33697

Quarters > 3 > income Statement > gross Profit

-33697

Quarters > 3 > income Statement > operating Expenses

6907952

Quarters > 3 > income Statement > operating Income

-6941650

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-5683107

Quarters > 3 > income Statement > net Income

-5683107

Quarters > 3 > income Statement > eps

-0.08137183835982663

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

69841202

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-5649411

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

1258543

Quarters > 3 > balance Sheet > cash

30580029

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

361621

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

31668159

Quarters > 3 > balance Sheet > property Plant Equipment

195592

Quarters > 3 > balance Sheet > total Assets

31863751

Quarters > 3 > balance Sheet > payables

6976736

Quarters > 3 > balance Sheet > short Term Debt

33009

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

7135268

Quarters > 3 > balance Sheet > equity

24728483

Quarters > 3 > cash Flow > net Income

-8178310

Quarters > 3 > cash Flow > depreciation

48493

Quarters > 3 > cash Flow > change In Working Capital

990411

Quarters > 3 > cash Flow > cash From Operations

-5593293

Quarters > 3 > cash Flow > capital Expenditures

6159

Quarters > 3 > cash Flow > cash From Investing

-6159

Quarters > 3 > cash Flow > cash From Financing

18690515

Quarters > 3 > cash Flow > net Change In Cash

14695011

Quarters > 3 > ratios > PE

-0.08137183835982663

Quarters > 3 > ratios > PB

3.0502679100857097

Quarters > 3 > ratios > ROE

-22.98202845682042

Quarters > 3 > ratios > ROA

-17.83564966974541

Quarters > 3 > ratios > FCF

-5599452

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

38

Valuation > metrics > PE

-0.1176039968463095

Valuation > metrics > PB

9.570838765280376

Valuation > final Score

20

Valuation > verdict

219.0% Overvalued

Profitability > metrics > ROE

-104.21934184894167

Profitability > metrics > ROA

-77.80449010761453

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.3542485389674062

Risk > metrics > Interest Coverage

-398.42276231850025

Risk > final Score

-1534

Risk > verdict

High

Liquidity > metrics > Current Ratio

346.8333107650643

Liquidity > metrics > Quick Ratio

346.8333107650643

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

20

Prev Valuations > 1

29.272967017371805

Prev Valuations > 2

49.497320899142906

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

15

Prev Risks > 0

4

Prev Risks > 1

-230

Prev Risks > 2

-764

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:21:51.562Z